Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Abbott designs novel focal adhesion kinase 1 inhibitors

May 7, 2012

Novel inhibitors of diacylglycerol O-acyltransferase 1 presented

May 7, 2012

Otsuka Pharmaceutical reports new candidate cancer therapies

May 7, 2012

St. Jude Children's Research Hospital presents new Mdm2/Mdm4 antagonists

May 4, 2012

NRC discloses new single-domain monoclonal antibodies

May 4, 2012

Novel Shp2 inhibitors developed in Germany

May 4, 2012

Merck Sharp & Dohme patents novel HER3-specific antibodies

May 4, 2012

New biologicals with anticancer potential discovered in Belgium

May 4, 2012

Novel NCK1/TCR interaction inhibitors designed in Spain

May 4, 2012

BioAnalytica discloses novel HSP 90-targeting antibodies

May 3, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...